Form 4 for RMD ResMed|
Accepted 2021-08-20 00:00:00 ET · period of report 2021-08-19 · accession 0001127602-21-024088 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-20 | 2021-08-19 | RMD | Farrell Michael J. | CEO | A - Grant | $0.00 | +18.4K | 424.6K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2021-08-19 | A | A | 18,418 | $0.00 | 424,611 | D | — | — | (F2) Includes 33.4591 shares of ResMed stock purchased on April 30, 2021, through the ResMed Employee Stock Purchase Plan. |